Image Guided Radiotherapy Market Size to grow by USD 927.5 million between 2024-2028

Technavio, a leading provider of market research reports, has released its latest study on Image Guided Radiotherapy Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges. The Image Guided Radiotherapy (IGRT) market witnesses significant growth due to the increasing prevalence of cancer and the subsequent rise in radiotherapy treatments. IGRT's precision and accuracy in delivering therapeutic doses make it a preferred choice for oncologists and patients. Advanced imaging technologies, such as CT, MRI, and ultrasound, enable real-time tumor tracking, enhancing treatment efficacy and patient safety. Market players focus on technological innovations and collaborations to expand their product portfolios and cater to the growing demand.

Key Highlights

Growth Projections

The global image guided radiotherapy market  size is estimated to grow by USD 927.5 mn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.11% during the forecast period. Rising incidence of cardiac diseases and growth of insurance providers is driving market growth, with a trend towards technological advancements  However, lack of adequate healthcare infrastructure in developing nations  poses a challenge.Key market players include Accuray Inc., Allengers Medical Systems Ltd., Boston Scientific Corp., C RAD AB, Canon Inc., Carestream Dental LLC, FUJIFILM Corp., General Electric Co., Hitachi Ltd., Hologic Inc., iCAD Inc., IsoRay Inc., Koninklijke Philips N.V., Medtronic Plc, Mevion Medical Systems Inc., Panacea Medical Technologies Pvt. Ltd., Siemens Healthineers AG, Varian Medical Systems Inc., ViewRay Inc., and Vision RT Ltd..

Know what is trending in the market - Access a free sample report! 

Major Findings

• The Image Guided Radiotherapy (IGRT) market is experiencing significant growth due to the increasing prevalence of cardiac diseases and the expansion of insurance coverage. With the rising number of cardiac patients requiring precise and effective radiation therapy, IGRT's ability to deliver targeted treatments with minimal healthy tissue damage has become increasingly valuable. Additionally, the growth of insurance providers offering coverage for advanced cancer treatments, including IGRT, is fueling market demand.


• The Image Guided Radiotherapy (IGRT) market is witnessing a significant surge due to an increasing number of collaborations and partnerships among industry players. These alliances aim to enhance technological advancements and improve the accuracy and effectiveness of IGRT treatments. Such collaborations contribute to the market's growth by expanding the reach and accessibility of these advanced therapies.


• In developing nations, the absence of sufficient healthcare infrastructure poses a significant challenge to the growth of the Image Guided Radiotherapy (IGRT) market. IGRT is a advanced technology that requires specialized equipment and skilled personnel for effective implementation. The scarcity of these resources in underdeveloped regions hampers the adoption of IGRT, thereby limiting market expansion. Despite the numerous benefits of IGRT in enhancing radiation therapy accuracy and reducing side effects, its implementation remains limited due to the inadequate healthcare infrastructure in these countries.


• The Image Guided Radiotherapy (IGRT) market growth is significantly influenced by the increasing adoption of advanced medical imaging technologies in radiation therapy. However, the high costs associated with these imaging modalities, such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), remain a major challenge. Healthcare providers must weigh the benefits of IGRT against the substantial investment required for implementation and maintenance. Despite this, the market is expected to grow due to the improved accuracy and personalized treatment plans offered by IGRT.

Market Research Overview

According to Technavio, the Image Guided Radiotherapy (IGRT) market is a significant segment within the expansive global healthcare equipment industry. This market encompasses organizations involved in the research and development (R&D) of advanced diagnostic equipment and devices used primarily for the treatment of various diseases. The global healthcare equipment market, as calculated by Technavio, represents the consolidated revenue generated by manufacturers of diagnostic instruments, implants, accessories, and consumables. The healthcare equipment sector is segmented into Devices, which includes sophisticated, differentiated, and data-driven devices, such as IGRT systems, that contribute significantly to the diagnosis, monitoring, and therapy processes.

The Image Guided Radiotherapy Market is experiencing significant growth, fueled by the Rising incidence of cardiac diseases and growth of insurance providers. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

For insights on company offerings- Request a sample report!

Regional Insights

The Image Guided Radiotherapy (IGRT) market signifies a significant growth trajectory in the healthcare industry. Leveraging advanced imaging technologies, IGRT enhances radiation therapy precision, leading to improved patient outcomes and reduced side effects. Market players focus on innovation, collaboration, and regulatory compliance to capitalize on this burgeoning sector. With increasing cancer prevalence and growing demand for personalized treatments, the IGRT market is poised for substantial expansion.

Research Analysis Overview

Image-guided radiotherapy (IGRT) is a crucial advancement in cancer care, merging medical technology and healthcare professionals to enhance the precision and effectiveness of radiation therapy. IGRT utilizes soft-tissue imaging, such as PET, MRI, and cone-beam CT, to provide real-time guidance during treatment, ensuring accurate targeting of cancerous tumors. This technology is particularly beneficial for older adults, who comprise a significant portion of the cancer patient population. Healthcare systems and oncologists are increasingly adopting IGRT to improve cancer treatment outcomes. However, the implementation of this technology requires extensive training for radiologists and other healthcare professionals to ensure optimal use and minimize adverse effects and surgical complications. The American Cancer Society and other healthcare organizations advocate for health equity in cancer care, emphasizing the importance of IGRT in the post-treatment phase. Non-invasive radiation therapies like IGRT and stereotactic radiosurgery (SRS) are increasingly popular, offering patients a more convenient and less invasive alternative to traditional surgical procedures. Computed tomography (CT) and radiotherapy are essential components of IGRT, allowing for precise image-guided delivery of radiation doses to cancerous tissue. By continually refining IGRT techniques and expanding access to this technology, healthcare systems can improve cancer treatment outcomes and enhance the overall patient experience.

About Technavio                                                                        

Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies. 

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/